Document Category: COVID and Post-Covid

Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series

Objective: A pandemic afflicts the entire world. The highly contagiousSARS-CoV-2 virus originated in Wuhan, China in late 2019 and rapidlyspread across the entire globe. According to the World Health Organization (WHO), the novel Coronavirus (COVID-19)has infectedmore than two million people worldwide, causing over 160,000 deaths.Patients with COVID-19 disease present with a wide array of symptoms,ranging …

Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series Read More »

View

Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?

Introduction: SARS-CoV-2 affects part of the innate immune response and activates an inflammatory cascade stimulating the release of cytokines and chemokines, particularly within the lung. Indeed, the inflammatory response during COVID-19 is likely the cause for the development of acute respiratory distress syndrome (ARDS). Patients with mild symptoms also show significant changes on pulmonary CT-scan …

Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19? Read More »

View

The evolving use of hyperbaric oxygen therapy during the COVID-19 pandemic

The Sars-CoV-2 (COVID-19) pandemic has resulted insignificant and unprecedented shifts in the delivery of health careservices in the United States. Although wound care remains anessential service during the COVID-19 pandemic, the financialconsequences and infectious disease ramifications of the pandemichave resulted in closure or limitation of hours in many outpatientwound and hyperbaric oxygen therapy (HBOT) centers. …

The evolving use of hyperbaric oxygen therapy during the COVID-19 pandemic Read More »

View